Steps taken after granting the Marketing Authorisation 
For procedures finalised after 1 November 2002 please refer to module 8B. 
Subsequent post Marketing Authorisation applications agreed upon are summarised in the table below: 
Scope 
Application 
number 
Type of 
modification1 
Change in pack size for a medicinal product 
Change in supplier of an intermediate compound 
used in manufacture of the active substance 
Minor change of manufacturing process of the 
active substance 
Minor change of manufacturing process of the 
active substance 
Minor change of manufacturing process of the 
active substance 
I/0001 
I/0002 
I/0003 
I/0004 
I/0005 
Change in the batch size of finished product 
I/0006 
I 
I  
I 
I 
I 
I 
Notification
/ 
Opinion 
issued on2 
05.04.00 
Commission 
Decision 
Issued/amen-
ded on 
16.11.00 
12.11.01 
N/A 
12.11.01 
N/A 
14.03.02 
N/A 
08.05.02 
N/A 
24.06.02 
N/A 
N/A 
61(3) Notification to update the update the contact 
details of local representatives 
N/0007 
N 
07.10.02 
1 For variations before 1 October 2003 in accordance with Commission Regulation (EC) No. 542/95 of 
10 March 1995, as amended: I refers to a minor variation (Type I variation); II refers to a major 
variation (Type II variation); I/II refers to a minor variation following the procedure set out in Article 
6, 7 and 8 of the Regulation; X refers to an Annex II application. 
T refers to a transfer of a Marketing Authorisation in accordance with Commission Regulation (EC) 
No 2141/96 of 7 November 1996.  
N refers to a notification in accordance with Article 61(3) of Council Directive 92/27/EEC of 31 
March 1992. 
2 For Notifications and Type I variations, the date of entry into force of the change is the EMEA 
Notification date. The Commission Decision will be amended accordingly  
1/1 
Â© EMEA 2004 
 
 
 
 
 
 
 
 
 
 
 
                                                      
 
